Bruker (BRKR) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1167941087

Microscopes, Spectrometry, Analyzers, Mass Spectrometry, Diagnostic Kits, X-ray Instruments

Bruker Corporation is a leading provider of scientific instruments, analytical, and diagnostic solutions. The company operates through four segments, each focusing on a specific area of expertise. These segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

The company offers a wide range of products and solutions, including life science tools, mass spectrometry, and molecular diagnostics kits. Their MALDI Biotyper platform is a rapid pathogen identification system, and they also provide DNA test strips and fluorescence-based polymerase chain reaction technology. Additionally, they offer research, analytical, and process analysis instruments and solutions.

In response to the COVID-19 pandemic, Bruker Corporation developed SARS-CoV-2 testing solutions for the diagnosis of COVID-19 infection, as well as Fluorotyper-SARS-CoV-2 plus kits. They also provide portable analytical and bioanalytical detection systems, X-ray instruments, and analytical tools for electron microscopes.

Their product portfolio also includes handheld, portable, and mobile X-ray fluorescence spectrometry instruments, atomic force microscopy instrumentation, and non-contact nanometer resolution solution topography. Furthermore, they offer advanced optical fluorescence microscopy instruments and products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery.

Bruker Corporation also develops and manufactures superconducting materials, including metallic low-temperature superconductors, as well as devices and complex tools based on these materials. They also provide non-superconducting high-technology tools, such as synchrotron and beamline instrumentation.

Founded in 1991, Bruker Corporation is headquartered in Billerica, Massachusetts, and has established itself as a leading player in the scientific instruments and analytical solutions industry. You can learn more about their products and services on their website:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Bruker (BRKR) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Bruker (BRKR) - Stock Price & Dividends

BRKR Stock Overview

Market Cap in USD 10,998m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2000-08-04

BRKR Stock Ratings

Growth 5y 4.51
Fundamental 36.3
Dividend 5.70
Rel. Performance vs Sector -1.07
Analysts 4.09/5
Fair Price Momentum 68.83 USD
Fair Price DCF 34.15 USD

BRKR Dividends

Yield 12m 0.26%
Yield on Cost 5y 0.48%
Dividends CAGR 5y 4.56%
Payout Consistency 98.0%

BRKR Growth Ratios

Growth 12m 2.06%
Growth Correlation 12m 27%
Growth Correlation 3m -46%
CAGR 5y 13.00%
CAGR/Mean DD 5y 0.75
Sharpe Ratio 12m -0.09
Alpha vs SP500 12m -31.52
Beta vs SP500 5y weekly 1.22
ValueRay RSI 43.59
Volatility GJR Garch 1y 50.00%
Price / SMA 50 -9.4%
Price / SMA 200 6.05%
Current Volume 1085.1k
Average Volume 20d 1365.2k

External Links for BRKR Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of BRKR stocks?
As of May 21, 2024, the stock is trading at USD 76.47 with a total of 1,085,063 shares traded.
Over the past week, the price has changed by +3.00%, over one month by -1.66%, over three months by -5.65% and over the past year by +1.14%.
What are the forecast for BRKR stock price target?
According to ValueRays Forecast Model, BRKR Bruker will be worth about 76.5 in May 2025. The stock is currently trading at 76.47. This means that the stock has a potential upside of +0.08%.
Issuer Forecast Upside
Wallstreet Target Price 83.9 9.72
Analysts Target Price 77.8 1.71
ValueRay Target Price 76.5 0.08